UPC Court of Appeal hears Sanofi’s challenge over cabazitaxel patent revocation
In one of the most prominent pharma cases at the UPC, oral proceedings in Sanofi’s appeal against the first-instance decision of the UPC’s Munich local division started today and are scheduled to continue tomorrow.